Skip to content

Patient Navigation and Peer Support to Improve Survivorship for Chinese- and Vietnamese-speaking People Affected by Cancer

Patient Navigation and Peer Support to Improve Survivorship for Chinese- and Vietnamese-speaking People Affected by Cancer – a Phase II Pragmatic Hybrid Effectiveness–Implementation Trial (the PEARL trial)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000536369
Acronym
PEARL
Enrollment
288
Registered
2026-04-30
Start date
2026-10-30
Completion date
2027-01-30
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

[ Why Are We Doing This Research? ] The purpose of this study is to test a bilingual, non-clinical patient navigation program designed to help Chinese- and Vietnamese-speaking cancer survivors overcome language, cultural, and health-system barriers as they transition from hospital treatment back to their local GP and community care. [ Who Is It For? ] You may be eligible for this study if you are aged 18 or older, speak Mandarin, Cantonese, or Vietnamese at home, and have completed active cancer treatment within the last two years. [ Study Details ] Participants in this study will be randomly allocated to one of two groups. Participants in one group will receive "usual care," which includes their standard follow-up appointments and standard survivorship information .The other group will participate in the PEARL program for 12 months. This involves: 1) meetings with a trained bilingual Patient Navigator to identify barriers and create a personalized care plan ; 2) support from a "Peer Facilitator" - a cancer survivor from your same cultural background who provides practical assistance and mentorship in your language ; and 3) assistance connecting with your GP to ensure you have a long-term plan for your health and wellbeing . As part of the study, all participants will answer a series of questionnaires at the start, at 6 months, and at 12 months . The findings will inform sustainable, culturally responsive models of cancer survivor-ship care in Australian primary care.

Interventions

The PEARL intervention is a non-clinical bilingual patient navigation and peer support program co-designed with cancer survivors, general practitioners, community organisations, multicultural health workers, and oncology clinicians to address language, cultural, and system-level barriers experienced by Chinese- and Vietnamese-speaking people after cancer treatment. The program strategically embeds trained bilingual Patient Navigators (PNs) and Peer Facilitators (PFs) within community and primary

The PEARL intervention is a non-clinical bilingual patient navigation and peer support program co-designed with cancer survivors, general practitioners, community organisations, multicultural health workers, and oncology clinicians to address language, cultural, and system-level barriers experienced by Chinese- and Vietnamese-speaking people after cancer treatment. The program strategically embeds trained bilingual Patient Navigators (PNs) and Peer Facilitators (PFs) within community and primary care settings to deliver culturally responsive survivorship support, improve coordination across care settings, and strengthen integration with general practice. Prior to participant enrolment, PNs and PFs will complete a structured training program delivered by members of the PEARL research team and senior project staff with expertise in cancer survivorship, patient navigation, and culturally and linguistically diverse (CALD) health. Training will be delivered via a combination of face-to-face workshops and/or videoconference sessions, depending on site location and availability. Training will comprise of three phases: Phase 1 and 3 will be delivered by PEARL staff with duration approximately 3 hours, and will occur at least three-four weeks before program commencement at each site. Phase 2 will involve self-directed completion of the free online George Washington Cancer Center's Oncology Patient Navigation Training course, which will take up to 14 hours (maximum). Core training content includes: the PEARL model and study procedures; roles and boundaries of PNs and PFs; culturally responsive communication; confidentiality and ethical conduct; documentation and data collection requirements; referral pathways; and escalation procedures. Refresher training and ad-hoc support will be provided as required throughout the study. Sites may nominate delegated staff to attend training to support local capacity building and facilitate training of additional PNs/PFs if required. The intervention consists of the following key elements: Initial patient navigation assessment and care planning: A trained bilingual PN will contact participants allocated to the intervention arm and arrange an initial assessment (face-to-face where feasible, otherwise via videoconference). This 30–60-minute meeting (including caregivers if preferred) identifies individual barriers to care—such as language, health literacy, psychosocial, logistical, or system obstacles—and results in a collaboratively developed, individualised care plan. The PN documents needs, establishes goals, and outlines actions to support the participant’s transition from specialist oncology care to primary care. Ongoing navigation and peer support: Following the initial assessment, each participant is linked with a trained PF who shares the participant’s preferred language and cultural background. PFs provide flexible, in-language support through phone, video, in-person meetings, and home visits where needed. Support includes: assisting with appointment booking and transport; helping participants understand medical information or written materials; clarifying clinician instructions; and providing practical and emotional support. PNs and PFs also assist with referrals to community services, allied health, psychosocial support, and other survivorship-related resources. The frequency and mode of contacts are tailored to participant needs and recorded in navigation activity logs. Culturally tailored survivorship education: Intervention participants are invited to attend a 6-week “Supporting People with Cancer” program delivered in Chinese/Vietnamese, offering culturally relevant education on symptoms, self-care, follow-up routines, and available supports. The program involves once-weekly sessions up to two hours long, delivered by a bilingual health professional and facilitator. Primary care integration: A central component of PEARL is strengthening the survivorship care role of general practitioners. GPs receive an enrolment notification, an overview of PEARL services, and contact details for the PN/PF. PNs facilitate communication between oncology teams and general practice and encourage development of chronic disease care plans where appropriate. GPs and practice nurses are offered a 15–30 minute multidisciplinary case conference with the PN, PF, and patient/carer to discuss care plans and clarify roles, following relevant Medicare requirements for case conferencing (e.g., MBS Item 735). This case conference may be offered within one week after participant enrolment. PNs may also visit general practices to support implementation and coordination of recommended follow-up care. Mode, duration, and tailoring: PEARL uses a hub-and-spoke delivery model across hospital, community, and primary care settings. Navigation and peer support are delivered over a 12-month period to align with annual survivorship surveillance. The intervention is tailored to cultural and linguistic needs, individual preferences, and the complexity of identified barriers, with adaptations documented using standard implementation frameworks. Adherence to the program will be assessed by the clinical trial coordinator or CPI on a fortnightly (for the first 3 months) and then monthly basis, by ensuring that the patient navigators are meeting the checklist of survivorship indicators.

Sponsors

Flinders University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Adults (18 years or older) who have completed active treatment with curative intent for any cancer (except non-melanoma skin cancer) within the past 2 years, or who are living with advanced cancer (treatable but not curable) • Speak Chinese (Mandarin/Cantonese) or Vietnamese at home • Agree for the research/patient navigation team to liaise with their GP and treating oncologist and to access GP/hospital records • May be receiving long-term endocrine, immunotherapy, or targeted therapy

Exclusion criteria

• Prior or current participation in a patient navigation program • Treatment with palliative intent only, with <6 months of life expectancy judged by the treating cancer specialist (urologist/oncologist) where it can be established • Unable or unwilling to provide informed consent • Plans to move overseas or interstate • At the discretion of the treating clinician, presence of severe mental, cognitive, or physical conditions that limit participation

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 17, 2026